The latest executive compensation regs proposed by the Securities and Exchange Commission won’t put any real brake on CEO pay excess. What would? We have a list!
A new online petition drive is protesting the incredibly high prices that enormously overpaid pharmaceutical company CEOs charge for cancer drugs.
Should America’s taxpayers be subsidizing all those millions in compensation that CEOs are collecting? At least some members of Congress don’t think so.
Researchers at the International Monetary Fund are detailing just how much societies suffer — and top execs grab — when trade unions have no strong presence. But IMF officials still aren’t paying attention.
The SEC finally moves, ever so slightly, against wagers that reward CEOs when their companies fail.
This year’s fast GDP growth underlines one of the great myths of economic statistics: the myth that growth benefits everyone, or at least most people.
Over the last 20 years, the annual lists of America’s highest-paid chief execs — our corporate ‘best and brightest’ — have included an amazingly high concentration of outright frauds and flops, as Institute for Policy Studies researchers show in their 20th annual Executive Excess report.
If world’s big corporations prefer to sit on trillions of dollars in order to avoid paying taxes, let them. If they won’t invest, we should.
The corrupting influence of inequality isn’t confined to politics. It is everywhere.
How can things be so much worse now when the economy is essentially in the same place it was five or six years ago? The answer in two words is: Rising inequality.